Ramtin Agah insider trades
Open-market stock purchases and sales by Ramtin Agah, Chief Medical Officer at RenovoRx, Inc, from SEC Form 4 filings since Aug 30, 2021.
Track record: 55% of 11 scored buys are up 5% or more since purchase, averaging -6%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 3, 2026 | RNXT RenovoRx, Inc | Bought (not open market) | — |
| Jan 21, 2026 | RNXT RenovoRx, Inc | Bought | $10K |
| Dec 31, 2025 | RNXT RenovoRx, Inc | Bought | $8.4K |
| Dec 30, 2025 | RNXT RenovoRx, Inc | Bought | $169 |
| Dec 16, 2025 | RNXT RenovoRx, Inc | Bought | $10.2K |
| Dec 5, 2025 | RNXT RenovoRx, Inc | Bought | $9.6K |
| Nov 24, 2025 | RNXT RenovoRx, Inc | Bought | $9.6K |
| Nov 21, 2025 | RNXT RenovoRx, Inc | Bought | $8K |
Companies traded
- RNXT RenovoRx, Inc: 14 buys, last Apr 3, 2026